PRF Technologies (PRFX) Change in Cash (2020 - 2024)
PRF Technologies' (PRFX) quarterly Change in Cash came in at $3.5 million in Q2 2024, up 217.78% YoY from $1.1 million in Q3 2023, and up 195.54% on a QoQ basis from -$3.7 million in Q1 2024.
PRF Technologies (PRFX) Change in Cash (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Change in Cash data on file, last reported at $3.5 million in Q2 2024.
- Quarterly Change in Cash rose 217.78% year-over-year to $3.5 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $2.7 million (up 131.22% YoY) and the FY2025 annual result came in at -$1.1 million, up 70.23% from the prior year.
- Change in Cash rose to $3.5 million in Q2 2024, from -$3.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.7 billion in Q3 2021 to a low of -$2.7 billion in Q4 2021.
- A 5-year average of $384666.7 and a median of -$671000.0 in 2020 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 15493.58% in 2021, down 131681.55% in 2021.
- Tracing PRFX's Change in Cash over 5 years: stood at -$2.0 million in 2020, then tumbled by 131681.55% to -$2.7 billion in 2021, then surged by 99.89% to -$2.8 million in 2022, then soared by 116.76% to $476000.0 in 2023, then jumped by 643.07% to $3.5 million in 2024.
- The last three Change in Cash figures came in at $3.5 million (Q2 2024), -$3.7 million (Q1 2024), and $476000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 476,000.00 |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -1.58 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.68 Bn |
| Sep 30, 2021 | 2.68 Bn |
| Jun 30, 2021 | -1.63 Mn |
| Mar 31, 2021 | 3.75 Mn |
| Dec 31, 2020 | -2.03 Mn |
| Sep 30, 2020 | 17.17 Mn |
| Jun 30, 2020 | -182,000.00 |
| Mar 31, 2020 | -215,000.00 |